Xiaoyuan Lu
Xuzhou, 221000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Risk Prediction Model for Progression-Free Survival in Endometrial Cancer Integrating Clinicopathological Variables and Routine Laboratory Indicators.
Journal: International journal of women's health
Published: April 15, 2026
Single-cell transcriptome analysis indicated that immune-related programmed cell death modification features could predict the clinical outcomes of patients with ovarian cancer.
Journal: Translational oncology
Published: February 02, 2026
Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.
Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.
Journal: Frontiers in immunology
Published: July 02, 2025
Analysis of Lymph Node Metastasis and Risk Factors in 424 Patients with Low-Grade Endometrioid Endometrial Carcinomas.
Journal: Gynecologic and obstetric investigation
Published: January 04, 2025
Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer.
Journal: Obstetrics and gynecology international
Published: December 30, 2024
FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight.
Journal: Current medicinal chemistry
Published: July 27, 2024
NAP1L1 Promotes Endometrial Cancer Progression via EP300-Mediated DDX5 Promoter Acetylation.
Journal: Molecular cancer research : MCR
Published: October 20, 2023
PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Journal: PloS one
Published: January 21, 2023
NOTCH Pathway Genes in Ovarian Cancer: Clinical Significance and Associations with Immune Cell Infiltration.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 19, 2022
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
Journal: International journal of endocrinology
Published: March 17, 2022
Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis.
Journal: International journal of general medicine
Published: July 07, 2021
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: June 14, 2021
Last Updated: 09/26/2026